HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cefditoren: Comparative efficacy with other antimicrobials and risk factors for resistance in clinical isolates causing UTIs in outpatients.

AbstractBACKGROUND:
To investigate a possible role of Cefditoren, a recently marketed in Greece third-generation oral cephalosporin in urinary infections of outpatients.
METHODS:
During a multicenter survey of Enterobacteriaceae causing UTIs in outpatients during 2005-2007, Cefditoren MICs were determined by agar dilution method in a randomly selected sample of uropathogens. Susceptibility against 18 other oral/parenteral antimicrobials was determined according to Clinical and Laboratory Standards Institute methodology.
RESULTS:
A total of 563 isolates (330 Escherichia coli, 142 Proteus mirabilis and 91 Klebsiella spp) was studied; MIC50/MIC90 of Cefditoren was 0.25/0.5 mg/L respectively, with 97.1% of the isolates being inhibited at 1 mg/L. All 12 strains producing ESBLs or AmpC enzymes were resistant to cefditoren. Susceptibility rates (%) for amoxicillin/clavulanic acid, cefuroxime axetil, cefotaxime, ciprofloxacin, trimethoprim/sulfamethoxazole and fosfomycin were 93.1- 94.1- 96.8-93.1-71.9 and 92.8% respectively. Cefditoren MIC was significantly higher in nalidixic/ciprofloxacin non-susceptible strains; resistance to cefditoren was not associated with resistance to mecillinam, fosfomycin nitrofurantoin and aminoglycosides. Multivariate analysis demonstrated history of urinary infection in the last two weeks or three months as risk factors for cefditoren resistance.
CONCLUSIONS:
Cefditoren exhibited enhanced in vitro activity against the most common uropathogens in the outpatient setting, representing an alternative oral treatment option in patients with risk factors for resistance to first-line antibiotics.
AuthorsDespina Hatzaki, Garyphallia Poulakou, Ioannis Katsarolis, Niki Lambri, Maria Souli, Ioannis Deliolanis, Georgios K Nikolopoulos, Evangelia Lebessi, Helen Giamarellou
JournalBMC infectious diseases (BMC Infect Dis) Vol. 12 Pg. 228 (Sep 25 2012) ISSN: 1471-2334 [Electronic] England
PMID23009290 (Publication Type: Journal Article, Multicenter Study)
Chemical References
  • Anti-Bacterial Agents
  • Cephalosporins
  • cefditoren
Topics
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Anti-Bacterial Agents (therapeutic use)
  • Cephalosporins (therapeutic use)
  • Drug Resistance, Bacterial
  • Enterobacteriaceae (drug effects, isolation & purification)
  • Enterobacteriaceae Infections (drug therapy, microbiology)
  • Female
  • Greece
  • Humans
  • Male
  • Microbial Sensitivity Tests
  • Middle Aged
  • Outpatients
  • Pregnancy
  • Risk Factors
  • Treatment Outcome
  • Urinary Tract Infections (drug therapy, microbiology)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: